Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Amplia Therapeutics Ltd. (INNMF) had Tangible Shareholders Equity of $20.86M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$21.86M |
|
-- |
|
$5.32M |
|
$27.42M |
|
$1.10M |
|
$0.17M |
|
$0.20M |
|
$1.30M |
|
$26.11M |
|
|
Tangible Shareholders Equity |
$20.86M |
$26.11M |
|
-- |
|
| Cash Flow Statement Financials | |
$-5.78M |
|
$-0.06M |
|
$17.16M |
|
$7.19M |
|
$18.43M |
|
$11.24M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|